Starling Oncology (STLNW) Net Income towards Common Stockholders Growth (3y) (2023 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Net Income towards Common Stockholders Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.22 Bn | 1.16 Bn | 11.68% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 11.57% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 18.42% |
| 4 | Concentra Group Holdings Parent | 4.26 Bn | 4.10 Bn | 192.10 Mn | 7.59% |
| 5 | Privia Health | 2.57 Bn | 2.15 Bn | - | 15.24% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 12.10% |
| 7 | Progyny | 2.11 Bn | 1.87 Bn | 89.30 Mn | 23.23% |
| 8 | Surgery Partners | 1.84 Bn | 1.63 Bn | 622.10 Mn | -19.86% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.15 Bn | 41.94 Mn | 0.08% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 21.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.29% |
| Mar 31, 2026 | 58.83% |
| Dec 31, 2025 | 16.42% |
| Sep 30, 2025 | -72.69% |
| Jun 30, 2025 | -36.90% |
| Mar 31, 2025 | -41.51% |
| Dec 31, 2024 | -2.91% |
| Sep 30, 2024 | -236.96% |
| Jun 30, 2024 | -27.48% |
| Mar 31, 2024 | -76.40% |
| Dec 31, 2023 | -16,637.01% |
| Sep 30, 2023 | -108.08% |
| Jun 30, 2023 | -86.17% |